$JRSH
Jerash Holdings (US), Inc. Stock $jrsh

$jrsh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024057324 Filed on June 28, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$40.94M	$21.57M	$117.2M
YoY Change	17.85%	-9.25%	-15.12%
Cost Of Revenue	$36.30M	$20.07M	$100.3M
YoY Change	24.44%	-5.85%	-13.75%
Gross Profit	$4.640M	$1.501M	$16.90M
YoY Change	-16.66%	-38.83%	-22.43%
Gross Profit Margin	11.33%	6.95%	14.42%
Selling, General & Admin	$5.000M	$4.521M	$16.58M
YoY Change	18.06%	5.55%	-2.24%
% of Gross Profit	107.76%	301.3%	98.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$612.8K	$657.9K	$2.540M
YoY Change	0.65%	-2.79%	4.49%
% of Gross Profit	13.21%	43.84%	15.03%
Operating Expenses	$5.469M	$4.521M	$17.57M
YoY Change	22.19%	5.55%	1.11%
Operating Profit	-$828.8K	-$3.021M	-$665.0K
YoY Change	-175.91%	65.03%	-115.06%
Interest Expense	-$480.2K	-$220.4K	-$1.204M
YoY Change	-223.46%	-17.68%	-256.69%
% of Operating Profit
Other Income/Expense, Net	$600.4K	$86.49K	$1.748M
YoY Change	-301.0%	-52.35%	-627.99%
Pretax Income	-$1.255M	-$3.155M	-$1.369M
YoY Change	-258.24%	64.59%	-133.53%
Income Tax	$111.7K	-$16.36K	$672.5K
% Of Pretax Income
Net Earnings	-$1.345M	-$3.089M	-$2.006M
YoY Change	-371.7%	55.66%	-182.9%
Net Earnings / Revenue	-3.29%	-14.32%	-1.71%
Basic Earnings Per Share	-$0.11		-$0.16
Diluted Earnings Per Share	-$0.11	-$0.25	-$0.16
COMMON SHARES
Basic Shares Outstanding	12.29M shares	12.29M shares	12.29M shares
Diluted Shares Outstanding	12.29M shares		12.29M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.37M	$12.43M	$12.43M
YoY Change	-38.43%	-30.18%	-30.18%
Cash & Equivalents	$11.37M	$12.43M
Short-Term Investments
Other Short-Term Assets	$6.148M	$5.832M	$5.832M
YoY Change	0.81%	30.16%	30.16%
Inventory	$20.73M	$27.24M	$27.24M
Prepaid Expenses
Receivables	$9.401M	$5.418M	$5.418M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$47.64M	$50.92M	$50.92M
YoY Change	-13.06%	-11.11%	-11.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.57M	$25.00M	$26.26M
YoY Change	5.67%	11.82%	12.55%
Goodwill	$499.3K	$499.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.767M	$2.569M	$2.569M
YoY Change	-3.63%	-1.4%	-1.4%
Total Long-Term Assets	$29.02M	$29.33M	$29.33M
YoY Change	5.26%	10.94%	10.94%
TOTAL ASSETS
Total Short-Term Assets	$47.64M	$50.92M	$50.92M
Total Long-Term Assets	$29.02M	$29.33M	$29.33M
Total Assets	$76.66M	$80.25M	$80.25M
YoY Change	-6.93%	-4.15%	-4.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.300M	$6.340M	$6.340M
YoY Change	-7.59%	9.64%	9.64%
Accrued Expenses	$3.426M	$4.176M	$4.547M
YoY Change	40.13%	42.49%	33.25%
Deferred Revenue	$246.0K	$10.20K
YoY Change		-98.9%
Short-Term Debt	$2.131M	$0.00	$0.00
YoY Change	-31.65%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.14M	$14.78M	$14.78M
YoY Change	-1.48%	2.3%	2.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$592.1K	$1.036M	$1.036M
YoY Change	-19.68%	-0.28%	-0.28%
Total Long-Term Liabilities	$592.1K	$1.036M	$1.036M
YoY Change	-19.68%	-0.28%	-0.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.14M	$14.78M	$14.78M
Total Long-Term Liabilities	$592.1K	$1.036M	$1.036M
Total Liabilities	$13.73M	$15.81M	$15.86M
YoY Change	-2.43%	2.13%	2.42%
SHAREHOLDERS EQUITY
Retained Earnings	$39.74M	$41.70M
YoY Change		-9.68%
Common Stock	$12.53K	$12.53K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.169M	$1.169M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$62.90M	$64.39M	$64.39M
YoY Change
Total Liabilities & Shareholders Equity	$76.66M	$80.25M	$80.25M
YoY Change	-6.93%	-4.15%	-4.15%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$1.345M	-$3.089M	-$2.006M
YoY Change	-371.7%	55.66%	-182.9%
Depreciation, Depletion And Amortization	$612.8K	$657.9K	$2.540M
YoY Change	0.65%	-2.79%	4.49%
Cash From Operating Activities	-$2.201M	-$5.382M	$2.485M
YoY Change	-8984.82%	-667.32%	-77.01%
INVESTING ACTIVITIES
Capital Expenditures	$130.3K	$416.9K	$1.241M
YoY Change	112.66%	-105.82%	71.73%
Acquisitions
YoY Change
Other Investing Activities	-$256.7K	-$462.1K	-$3.902M
YoY Change	-85.0%	-95.17%	-70.11%
Cash From Investing Activities	-$387.0K	-$879.0K	-$5.143M
YoY Change	-78.17%	-63.42%	-62.67%
FINANCING ACTIVITIES
Cash Dividend Paid	$614.7K		$2.459M
YoY Change	0.0%		-1.01%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.516M	-614.7K	-$2.428M
YoY Change	-39.42%	-88.66%	-38.59%
NET CHANGE
Cash From Operating Activities	-$2.201M	-5.382M	$2.485M
Cash From Investing Activities	-$387.0K	-879.0K	-$5.143M
Cash From Financing Activities	$1.516M	-614.7K	-$2.428M
Net Change In Cash	-$1.063M	-6.876M	-$5.375M
YoY Change	-261.15%	-0.01%	-25.06%
FREE CASH FLOW
Cash From Operating Activities	-$2.201M	-$5.382M	$2.485M
Capital Expenditures	$130.3K	$416.9K	$1.241M
Free Cash Flow	-$2.331M	-$5.799M	$1.243M
YoY Change	6289.35%	-171.48%	-87.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38474
CY2024	dei	Entity Registrant Name EntityRegistrantName	Jerash Holdings (US), Inc.
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-4701719
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	277 Fairfield Road
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 338
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Fairfield
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07004
CY2024	dei	City Area Code CityAreaCode	(201)
CY2024	dei	Local Phone Number LocalPhoneNumber	285-7973
CY2024	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024	dei	Trading Symbol TradingSymbol	JRSH
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	21963152	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12294840	shares
CY2024	dei	Auditor Firm AuditorFirmId	688
CY2024	dei	Auditor Name AuditorName	Marcum llp
CY2024	dei	Auditor Location AuditorLocation	Costa Mesa, CA
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12428369	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17801614	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5417513	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2240537	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	87573	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	27241573	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	32656833	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2746068	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2964578	usd
CY2024Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	3086137	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1533091	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	50919660	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	57284226	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1608498	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1609989	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	802306	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	841628	usd
CY2024Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	158329	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	153873	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24998096	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22355574	usd
CY2024Q1	us-gaap	Goodwill Goodwill	499282	usd
CY2023Q1	us-gaap	Goodwill Goodwill	499282	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1259395	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	974761	usd
CY2024Q1	us-gaap	Assets Assets	80245566	usd
CY2023Q1	us-gaap	Assets Assets	83719333	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6340237	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5782570	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4175843	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2930533	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1647199	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2846201	usd
CY2024Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2234870	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1477243	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10200	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	928393	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	370802	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	481502	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14779151	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14446442	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	618302	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	287247	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	417450	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	751410	usd
CY2024Q1	us-gaap	Liabilities Liabilities	15814903	usd
CY2023Q1	us-gaap	Liabilities Liabilities	15485099	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12534318	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12534318	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12294840	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12294840	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	12534	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12534	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23917094	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22931046	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	239478	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	239478	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1169046	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1169046	usd
CY2024Q1	jrsh	Statutory Reserve StatutoryReserve	413821	usd
CY2023Q1	jrsh	Statutory Reserve StatutoryReserve	410847	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41704238	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46172082	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-492319	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-123229	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	64386322	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	68234234	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	44341	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64430663	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	68234234	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80245566	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83719333	usd
CY2024	us-gaap	Revenues Revenues	117187340	usd
CY2023	us-gaap	Revenues Revenues	138063309	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	100284991	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	116273569	usd
CY2024	us-gaap	Gross Profit GrossProfit	16902349	usd
CY2023	us-gaap	Gross Profit GrossProfit	21789740	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16581256	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16960978	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	986048	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	413900	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	17567304	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	17374878	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-664955	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	4414862	usd
CY2024	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1203596	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	768131	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	499120	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	437002	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-704476	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-331129	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1369431	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4083733	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	672495	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1664110	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-2041926	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2419623	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-36024	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2005902	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2419623	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-2041926	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2419623	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	369090	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	250374	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2411016	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2169249	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-36024	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2374992	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2169249	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12294840	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12635785	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12294840	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12675351	shares
CY2024	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	69304258	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	413900	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1169046	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2419623	usd
CY2023	us-gaap	Dividends Dividends	2484127	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-250374	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	68234234	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	68234234	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	986048	usd
CY2024	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	31365	usd
CY2024	jrsh	Stock Issued During Period Value Allocation Of Jerash Newtech Shares StockIssuedDuringPeriodValueAllocationOfJerashNewtechShares	49000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-2041926	usd
CY2024	us-gaap	Dividends Dividends	2458968	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-369090	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64430663	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-2041926	usd
CY2023	us-gaap	Profit Loss ProfitLoss	2419623	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2539736	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2430692	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	986048	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	413900	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-187762	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	759764	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	989220	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2989214	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8808532	usd
CY2024	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-87573	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	87573	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5415260	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4401654	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-187140	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-285782	usd
CY2024	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	1553046	usd
CY2023	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	248490	usd
CY2024	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	4456	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-198717	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	557667	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	942345	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1245310	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-185421	usd
CY2023Q1	us-gaap	Subsidiary Or Equity Method Investee Cumulative Proceeds Received On All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions	64000	usd
CY2023Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29900000	usd
CY2024	jrsh	Increase Decrease In Other Payables IncreaseDecreaseInOtherPayables	757627	usd
CY2023	jrsh	Increase Decrease In Other Payables IncreaseDecreaseInOtherPayables	-801574	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-918193	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	928393	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-824043	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-977584	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1532944	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	92226	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2484541	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10807134	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1241226	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	722770	usd
CY2024	jrsh	Payments For Construction Of Properties PaymentsForConstructionOfProperties	3600948	usd
CY2023	jrsh	Payments For Construction Of Properties PaymentsForConstructionOfProperties	5084044	usd
CY2023	jrsh	Paymentfor Acquisition Of Ever Winland PaymentforAcquisitionOfEverWinland	5100000	usd
CY2023	jrsh	Paymentfor Acquisition Of Kawkab Venus PaymentforAcquisitionOfKawkabVenus	2200000	usd
CY2024	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	300762	usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	668337	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5142936	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13775151	usd
CY2024	us-gaap	Payments Of Dividends PaymentsOfDividends	2458968	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	2484127	usd
CY2024	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	31365	usd
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	1169046	usd
CY2024	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	7545829	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	7197995	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300166	usd
CY2024	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7545829	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7197995	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2427603	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3953339	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-288738	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-250529	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5374736	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7171885	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19411603	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26583488	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14036867	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19411603	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14036867	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19411603	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1608498	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1609989	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12428369	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17801614	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	1203596	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	768131	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2253410	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1747635	usd
CY2024	jrsh	Equipment Obtained By Utilizing Longterm Deposit EquipmentObtainedByUtilizingLongtermDeposit	354917	usd
CY2023	jrsh	Equipment Obtained By Utilizing Longterm Deposit EquipmentObtainedByUtilizingLongtermDeposit	237412	usd
CY2023	jrsh	Acquisition Of Kawkab Venus By Utilizing Longterm Deposit AcquisitionOfKawkabVenusByUtilizingLongtermDeposit	500000	usd
CY2024	jrsh	Operating Lease Right Of Use Assets Obtained In Exchange For Operating Lease Obligations OperatingLeaseRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligations	1058820	usd
CY2023	jrsh	Operating Lease Right Of Use Assets Obtained In Exchange For Operating Lease Obligations OperatingLeaseRightOfUseAssetsObtainedInExchangeForOperatingLeaseObligations	190654	usd
CY2023Q1	us-gaap	Subsidiary Or Equity Method Investee Cumulative Proceeds Received On All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions	500000	hkd
CY2023Q4	us-gaap	Subsidiary Or Equity Method Investee Cumulative Proceeds Received On All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions	100000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	44341	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.</p>
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3097031	usd
CY2024Q1	us-gaap	Goodwill Goodwill	499282	usd
CY2023Q1	us-gaap	Goodwill Goodwill	499282	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10200	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	928393	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10200	usd
CY2024	us-gaap	Other Expenses OtherExpenses	1748317	usd
CY2023	us-gaap	Other Expenses OtherExpenses	1856218	usd
CY2022	jrsh	Social Contribution Percentage SocialContributionPercentage	0.01	pure
CY2023Q1	jrsh	Social Contribution Percentage SocialContributionPercentage	0.01	pure
CY2024Q1	jrsh	Social Contribution Percentage SocialContributionPercentage	0.01	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.50	pure
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2932519	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9479719	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentrations and Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Credit risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of March 31, 2024 and 2023, respectively, $6,547,090 and $7,264,247 of the Company’s cash were on deposit at financial institutions in Jordan, where there currently is no rule or regulation requiring such financial institutions to maintain insurance to cover bank deposits in the event of bank failure. As of March 31, 2024 and 2023, respectively, $518,485 and $172,939 of the Company’s cash was on deposit at financial institutions in China. Cash maintained in banks within China of less than CNY0.5 million (equivalent to $69,262) per bank is covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China. As of March 31, 2024 and 2023, respectively, $6,682,404 and $11,700,512 of the Company’s cash were on deposit at financial institutions in Hong Kong, which are insured by the Hong Kong Deposit Protection Board subject to certain limitations. While management believes that these financial institutions are of high credit quality, it also continually monitors their creditworthiness. As of March 31, 2024 and 2023, respectively, $267,954 and $171,496 of the Company’s cash were on deposit in the United States and are insured by the Federal Deposit Insurance Corporation up to $250,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are typically unsecured and derived from revenue earned from customers, and therefore are exposed to credit risk. The risk is mitigated by the Company’s assessment of its customers’ creditworthiness and its ongoing monitoring of outstanding balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Customer and vendor concentration risk</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s sales are made primarily in the United States. Its operating results could be adversely affected by U.S. government policies on importing business, foreign exchange rate fluctuations, and changes in local market conditions. The Company has a concentration of its revenue and purchases with specific customers and suppliers. For the fiscal year ended March 31, 2024 and 2023, two customers accounted for 67% and 12%, and 60% and 17% of the Company’s total revenue, respectively. As of March 31, 2024, four end-customers accounted for 23%, 23%, 10%, and 10%, respectively, of the Company’s total accounts receivable balance. As of March 31, 2023, four end-customers accounted for 50%, 13%, 10%, and 10%, respectively, of the Company’s total accounts receivable balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fiscal years ended March 31, 2024 and 2023, the Company purchased approximately 10% and 11%, respectively, of its total purchase from one major garment supplier. As of March 31, 2024, accounts payable to the Company’s two major suppliers accounted for 22% and 13% of the total accounts payable balance, respectively. As of March 31, 2023, accounts payable to the Company’s one major supplier accounted for 36% of the total accounts payable balance, respectively.</p>
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	14664823	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	15240198	usd
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no effect on net income or cash flow as previously reported.</p>
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5451334	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2462120	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33821	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	221583	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	5417513	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	2240537	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14484116	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	27241573	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	32656833	usd
CY2024	jrsh	Inventory Based Orders Received Percentage InventoryBasedOrdersReceivedPercentage	0.999	pure
CY2023	jrsh	Inventory Based Orders Received Percentage InventoryBasedOrdersReceivedPercentage	0.934	pure
CY2024	jrsh	Inventories Held On Hand Unfulfilled Sales Orders Percentage InventoriesHeldOnHandUnfulfilledSalesOrdersPercentage	0.001	pure
CY2023	jrsh	Inventories Held On Hand Unfulfilled Sales Orders Percentage InventoriesHeldOnHandUnfulfilledSalesOrdersPercentage	0.066	pure
CY2024Q1	jrsh	Advances On Inventory Purchases Gross AdvancesOnInventoryPurchasesGross	3086137	usd
CY2023Q1	jrsh	Advances On Inventory Purchases Gross AdvancesOnInventoryPurchasesGross	1533091	usd
CY2024Q1	us-gaap	Supplies Supplies	3086137	usd
CY2023Q1	us-gaap	Supplies Supplies	1533091	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1259395	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	370802	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	618302	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	989104	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061	pure
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	2561861	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	2696593	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	599970	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	475019	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	275443	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9281	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1359713	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	100318	usd
CY2024Q1	jrsh	Lessee Operating Lease Liability Prepayments LesseeOperatingLeaseLiabilityPrepayments	270291	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	989104	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32071337	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29315676	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16624019	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14142469	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24998096	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22355574	usd
CY2023Q4	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	874000	jod
CY2023Q4	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1233000	usd
CY2022Q2	us-gaap	Area Of Land AreaOfLand	4516	sqm
CY2022Q2	us-gaap	Area Of Land AreaOfLand	48608	sqft
CY2024Q1	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	6600000	jod
CY2024Q1	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	9300000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Salvage Value PropertyPlantAndEquipmentSalvageValue	195000	jod
CY2024Q1	us-gaap	Property Plant And Equipment Salvage Value PropertyPlantAndEquipmentSalvageValue	274000	usd
CY2022Q3	us-gaap	Contributions In Aid Of Construction ContributionsInAidOfConstruction	39600000	hkd
CY2022Q3	us-gaap	Contributions In Aid Of Construction ContributionsInAidOfConstruction	5100000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2539736	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2430692	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12294840	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12294840	shares
CY2024Q1	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	239478	shares
CY2024	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	1169046	usd
CY2024	jrsh	Statutory Reserve Percentage StatutoryReservePercentage	0.10	pure
CY2024	jrsh	Entitys Share Capital Percentage EntitysShareCapitalPercentage	1	pure
CY2024	jrsh	Aftertax Net Profits Percentage AftertaxNetProfitsPercentage	0.10	pure
CY2024	jrsh	Percentage Of Registered Capital Reserves PercentageOfRegisteredCapitalReserves	0.50	pure
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	614742	usd
CY2023Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	614742	usd
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	614742	usd
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	614742	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	618886	usd
CY2022Q4	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	621809	usd
CY2022Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	626716	usd
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	616716	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	137210	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	57200	shares
CY2018Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1484250	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	114110	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1136500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.9
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	986500	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.25
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	986500	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150000	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M18D
CY2022Q2	jrsh	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Option EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOption	200000	usd
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	1937695	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	846775	usd
CY2024	jrsh	Sharebased Compensation Arrangement By Sharebased Payment Award Rs Us Remained SharebasedCompensationArrangementBySharebasedPaymentAwardRSUsRemained	405100	shares
CY2024	us-gaap	Restricted Stock Expense RestrictedStockExpense	986048	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	413900	usd
CY2024	us-gaap	Payments For Fees PaymentsForFees	1122019	usd
CY2023	us-gaap	Payments For Fees PaymentsForFees	647906	usd
CY2023Q2	jrsh	Document Received DocumentReceived	10000000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1470140	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1193700	shares
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2005000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2420000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12294840	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12635785	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	39566	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12294840	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12675351	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024	us-gaap	Revenues Revenues	117187340	usd
CY2023	us-gaap	Revenues Revenues	138063309	usd
CY2019Q3	us-gaap	Capital Units CapitalUnits	3000000	hkd
CY2019Q3	us-gaap	Capital Units CapitalUnits	385000	usd
CY2020Q4	us-gaap	Capital Units CapitalUnits	15000000	hkd
CY2020Q4	us-gaap	Capital Units CapitalUnits	1900000	usd
CY2024	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	15000000	hkd
CY2024	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	1900000	usd
CY2024	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	10000000	hkd
CY2024	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	1300000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01	pure
CY2024Q1	us-gaap	Remaining Recovery Period Of Regulatory Assets For Which No Return On Investment During Recovery Period Is Provided1 RemainingRecoveryPeriodOfRegulatoryAssetsForWhichNoReturnOnInvestmentDuringRecoveryPeriodIsProvided1	P2Y
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	751410	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2189825	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1761439	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	820394	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5845172	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1369431	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4083733	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	750	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	750	usd
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	676201	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1464643	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	676951	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1465393	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4456	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	198717	usd
CY2024	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-4456	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	198717	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	672495	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1664110	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.491	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.407	pure
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-287581	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	857052	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	593	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	593	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Depletion IncomeTaxReconciliationNondeductibleExpenseDepletion	202789	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Depletion IncomeTaxReconciliationNondeductibleExpenseDepletion	85589	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	527733	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	846116	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	274877	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	558642	usd
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	503917	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	237688	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	793383	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	1372649	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	793383	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1372649	usd
CY2024	jrsh	Income Tax Reconciliation Provision To Return Adjustments IncomeTaxReconciliationProvisionToReturnAdjustments	-79	usd
CY2023	jrsh	Income Tax Reconciliation Provision To Return Adjustments IncomeTaxReconciliationProvisionToReturnAdjustments	195714	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	672495	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1664110	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	158557	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	154227	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	228	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	354	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2166032	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1372649	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2166032	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1372649	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	158329	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	153873	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2166032	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1372649	usd
CY2024Q1	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	15000000	usd
CY2024	us-gaap	Deferred Tax Liability Not Recognized Events That Would Cause Temporary Difference To Be Taxable Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedEventsThatWouldCauseTemporaryDifferenceToBeTaxableUndistributedEarningsOfForeignSubsidiaries	$3.2
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	jrsh	Non Rule10b51 Arr Modified Flag NonRule10b51ArrModifiedFlag	false
CY2024Q1	jrsh	Rule10b51 Arr Modified Flag Rule10b51ArrModifiedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Minority Interest MinorityInterest		usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	jrsh	Stock Issued During Period Value Statutory Reserve StockIssuedDuringPeriodValueStatutoryReserve		usd
CY2024	jrsh	Stock Issued During Period Value Statutory Reserve StockIssuedDuringPeriodValueStatutoryReserve		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2024	jrsh	Paymentfor Acquisition Of Ever Winland PaymentforAcquisitionOfEverWinland		usd
CY2024	jrsh	Paymentfor Acquisition Of Kawkab Venus PaymentforAcquisitionOfKawkabVenus		usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2024	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity		usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2024	jrsh	Acquisition Of Kawkab Venus By Utilizing Longterm Deposit AcquisitionOfKawkabVenusByUtilizingLongtermDeposit		usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P2Y
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount		usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount		usd
CY2024	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2024	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable		usd
CY2023	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001696558

Files In Submission

Name	View Source	Status
0001213900-24-057324-index-headers.html	Edgar Link	pending
0001213900-24-057324-index.html	Edgar Link	pending
0001213900-24-057324.txt	Edgar Link	pending
0001213900-24-057324-xbrl.zip	Edgar Link	pending
ea0207691-10k_jerash.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
jrsh-20240331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
jrsh-20240331_cal.xml	Edgar Link	unprocessable
ea020769101ex19-1_jerash.htm	Edgar Link	pending
ea020769101ex21-1_jerash.htm	Edgar Link	pending
ea020769101ex23-1_jerash.htm	Edgar Link	pending
ea020769101ex31-1_jerash.htm	Edgar Link	pending
ea020769101ex31-2_jerash.htm	Edgar Link	pending
ea020769101ex32-1_jerash.htm	Edgar Link	pending
ea020769101ex32-2_jerash.htm	Edgar Link	pending
ea020769101ex97-1_jerash.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
jrsh-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
jrsh-20240331_lab.xml	Edgar Link	unprocessable
jrsh-20240331_pre.xml	Edgar Link	unprocessable
ea0207691-10k_jerash_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JRSH
Jerash Holdings (US), Inc. Stock $jrsh

2024 Q2 Form 10-K Financial Statement

#000121390024057324 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSH Jerash Holdings (US), Inc. Stock $jrsh

2024 Q2 Form 10-K Financial Statement

#000121390024057324 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSH
Jerash Holdings (US), Inc. Stock $jrsh